UK-based Autolus Ltd has made a submission to the US Securities and Exchange Commission relating to a potential initial public offering of its shares. As of 8 March, the timing and terms of the potential offering had not been determined. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals
